|
Volumn 112, Issue 6, 2005, Pages 710-712
|
Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: A report of 10 cases
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
CANDESARTAN;
FUROSEMIDE;
HYDROCHLOROTHIAZIDE;
IRBESARTAN;
LOSARTAN;
METHYLDOPA;
QUINAPRIL;
VALSARTAN;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEMOGRAPHY;
DRUG CONTRAINDICATION;
ECHOGRAPHY;
ESSENTIAL HYPERTENSION;
FACE DYSMORPHIA;
FEMALE;
FETOTOXICITY;
FETUS DEATH;
FOLLOW UP;
HUMAN;
INDUCED ABORTION;
KIDNEY MALFORMATION;
MACROCEPHALY;
OLIGOHYDRAMNIOS;
PERINATAL DEVELOPMENT;
PREGNANCY COMPLICATION;
PREGNANCY TERMINATION;
PRENATAL DEVELOPMENT;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
STILLBIRTH;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ADULT;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANTIHYPERTENSIVE AGENTS;
FEMALE;
FETUS;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION, PREGNANCY-INDUCED;
PREGNANCY;
PROSPECTIVE STUDIES;
RENIN-ANGIOTENSIN SYSTEM;
TERATOGENS;
ULTRASONOGRAPHY, PRENATAL;
|
EID: 20744435472
PISSN: 14700328
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1471-0528.2004.00525.x Document Type: Article |
Times cited : (60)
|
References (6)
|